US5571143A - Heart Stimulator - Google Patents

Heart Stimulator Download PDF

Info

Publication number
US5571143A
US5571143A US08467267 US46726795A US5571143A US 5571143 A US5571143 A US 5571143A US 08467267 US08467267 US 08467267 US 46726795 A US46726795 A US 46726795A US 5571143 A US5571143 A US 5571143A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
atrial
pole
ventricular
signal
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08467267
Inventor
Kurt Hoegnelid
Hans Strandberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacesetter AB
Original Assignee
Pacesetter AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date
Family has litigation

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions

Abstract

A heart stimulator having a pulse generator and an electrode system, which contain at least one bipolar electrode with one pole arranged in the atrium and another pole in the ventricle, or at least two unipolar electrodes respectively arranged in the atrium and ventricle, for detecting atrial and ventricular activity includes an atrial measurement unit which is connected for measuring a signal between the two poles of the bipolar electrode, or between the two unipolar electrodes, and a ventricular measurement unit arranged to measure the signals between the ventricular pole (or electrode) and the housing of the stimulator.

Description

This is a continuation of application Ser. No. 08/147,774, filed Nov. 4, 1993.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention is directed to a heart stimulator of the type having a pulse generator and an electrode system which contains at least one bipolar electrode with one pole arranged in the atrium and one pole in the ventricle, or at least two unipolar electrodes respectively arranged in the atrium and ventricle, for detecting atrial and ventricular activity.

2. Description of the Prior Art

Electrode systems of the type generally described above are disclosed in U.S. Pat. No. 4,154,247 and U.S. Pat. No. 4,567,901.

DDD pacemakers are currently used for treating patients with bradycardia. A conventional DDD pacemaker requires two electrodes, each with its own lead. One of the electrodes is placed in the atrium and the other in the ventricle. Electrical activity is sensed with the electrodes, and stimulation pulses are emitted when spontaneous electrical activity is not present.

There has long been a desire for DDD pacemakers employing only one electrode lead, i.e., a single lead DDD pacemaker. This would greatly simply implantation, compared to the currently required implantation of two separate and basically parallel leads.

The VDD pacemaker, using only one electrode with poles in the atrium and ventricle, is a step toward a single lead DDD pacemaker design. The poles in the atrium are "floating," i.e., they are normally not in direct contact with electrically active atrial tissue. The electrode system passes through both the atrium and the ventricle. This type of VDD electrode system contains three leads in instances wherein a unipolar electrode is employed in the ventricle, and contains four leads in instances wherein a bipolar electrode is employed in the ventricle.

SUMMARY OF THE INVENTION

It is an object of the present invention to provide a heart stimulator permitting detection of atrial and ventricular cardiac activity in a bipolar mode and having an electrode system employing a minimum number of poles or electrodes, plus attendant leads.

The above object is achieved in accordance with the principles of the present invention in a heart stimulator having a hear stimulating having a pulse generator and an electrode system which contains at least one bipolar electrode with one pole arranged in the atrium and one pole in the ventricle, or at least two unipolar electrodes respectively arranged in the atrium and ventricle, for detecting atrial and ventricular electrical activity, and having an atrial measurement unit arranged to measure a signal between the two poles of the bipolar electrode, or between the two unipolar electrodes, and a ventricular measurement unit arranged to measure a signal between the ventricular pole (or electrode) and the stimulator housing.

In the heart stimulator according to the invention, one lead terminates in a pole or electrode placed in the atrium, and a second lead terminates in a pole or electrode disposed in the ventricle. Atrial activity is sensed between the atrial pole or electrode and the ventricular electrode, while ventricular electrical activity is measured between the pole or electrode in the ventricle and the stimulator housing. In principle, a bipolar system for atrial detection is obtained when measurement of the atrial activity is between poles or electrodes in the atrium and in the ventricle. Atrial signals are often so weak that interference from muscular activity causes problems in measurements in the atrium, and bipolar electrodes have therefore often been used in the atrium in order to minimize such muscular interference. With the system according to the present invention, therefore, such a bipolar measurement system is achieved so as to avoid interference from muscular activity with no need for a bipolar electrode in the atrium.

Since ventricular events are also detected by the atrial measurement unit, whereas atrial electrical events are only detected by the atrial measurement unit, a logic unit is provided in a further embodiment of the heart stimulator of the invention, which approves the signal from the measurement unit as an atrial event only if the ventricular measurement unit fails to detect any signal occurring during a defined period of time around the time an atrial signal is measured. This particular technique is disclosed in Swedish Patent Application No. 9203171-5, corresponding to a U.S. Pat. No. 5,400,796.

In a further embodiment of the invention, a second pole arranged in the atrium is connected, through a resistor, to the lead for the ventricular pole. The resistor has a value in the range of 1-20 kohms. As a result of the resistor, this pole cannot be employed for stimulation in the atrium, because resistance is lower in the ventricular pole connected to the same lead. The value of the resistor must not be too low, however, otherwise the connected atrial pole would then draw current making stimulation through the ventricular pole more difficult or impossible. Even in this instance, ventricular activity is sensed via the ventricular pole, and atrial activity is sensed between the two atrial poles. This means that signals corresponding to both ventricular and atrial activity are carried by the same lead. The atrial signal, however, has a considerably lower amplitude than the ventricular signal because the voltage of the atrial signal is split (divided) because of the resistor. The sensitivity of the ventricular measurement unit is therefore set so that it detects the strong ventricular signals but not the weak atrial signals. Atrial activity is measured between the poles in the atrium, as noted above, and the logic unit approves the signal from the atrial measurement unit as a genuine atrial event only if no ventricular signal is contemporaneously present.

The division in the voltage of the detected atrial signal depends on the magnitude of the resistor used for the second atrial pole. If a 1 kohm resistor, for example, is used, about 1/10 of the atrial signal reaches the heart stimulator. In practice, the ventricular electrode then also serves as the indifferent electrode for sensed atrial signals. The pole or poles in the atrium can be "floating," i.e., not be in direct contact with electrically active tissue, if they are only to be used for detecting electrical activity. If the electrode system is devised, however, so that the atrial pole, which is directly connected to its lead, is in direct contact with atrial tissue, the atrial pole can also be used for stimulating the atrium. This results in a single lead DDD pacemaker employing only two leads in the electrode cable.

If a bipolar electrode is employed in the ventricle, three leads are required within the electrode cable.

DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic drawing of a heart stimulator constructed in accordance with the principles of the present invention with a bipolar electrode implanted in a heart.

FIG. 2 shows signals obtained with the heart stimulator shown in FIG. 1.

FIG. 3 schematically shows a heart stimulator constructed in accordance with the principles of the present invention having an implanted electrode system using two unipolar electrodes.

FIG. 4 schematically shows a further embodiment of the heart stimulator according to the invention with two poles in the atrium.

FIG. 5 shows signals obtained with the embodiment of the invention shown in FIG.4.

FIGS. 6 and 7 respectively schematically show practical implementations of the embodiments of FIGS. 3 and 4.

FIG. 8 shows the signals detected by the atrial and ventricular measurement units in the heart stimulator of the invention in experiments conducted with animals.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

FIG. 1 schematically shows an electrode system according to the invention implanted in a heart 2. The electrode system contains a bipolar electrode with one pole 4 arranged in the atrium and one pole 6 arranged in the ventricle. The electrode system has a single electrode cable containing respective leads 10 and 12 for the poles 4 and 6.

The stimulator housing is schematically indicated at 14.

The leads 10 and 12 are connected to input terminals of an atrial measurement unit 16. The lead 12 is connected in a like manner to one of the input terminals of a ventricular measurement unit 18. The other input terminal of the ventricular measurement unit 18 is connected to the stimulator housing 14.

The atrial measurement unit 16 thus measures the signal between the poles 4 and 6. The atrial measurement unit 16, however, detects both atrial and ventricular electrical events, because the lead 12 from the ventricular pole 6 is directly connected to the measurement unit 16. The output signal from the measurement unit 16 is therefore connected to one of two input terminals of an AND gate 20. The output signal from the ventricular measurement unit 18 is supplied, via a negating (inverting) element 22 to the other input to the AND gate 20. An output signal At is thus obtained from the output of the AND gate 20 when an atrial event is detected without the substantially contemporaneous detection of any ventricular event, occurring at about the time of the atrial detection. Monitoring of the ventricular signal must therefore be conducted for a sufficiently long period of time around the time the atrial event is detected. The output signal At constitutes the detection of a genuine atrial event.

The ventricular measurement unit 18 emits an output signal Vdet, which directly designates ventricular events.

FIG. 2 shows an extracorporeally-obtained electrocardiograph (EKG) signal Y(t) signals Adet and Vdet in the form of output pulses appearing at the respective output terminals of the atrial and ventricular measurement units 16 and 18, and the output signal At from the AND gate 20.

In the embodiment of FIG. 1, the atrial pole 4 is floating, i.e., it is not in direct contact with atrial tissue. The atrial pole 4 in the embodiment of FIG. 1, therefore, is not suitable for stimulation, and is used only for sensing atrial events.

In the embodiment of FIG. 3, the electrode system contains unipolar electrodes 24 and 26 respectively disposed in the atrium and ventricle. In this embodiment, the atrial electrode 24 is arranged in direct contact with atrial heart tissue, making effective stimulation of the atrium also possible. FIG. 3 thus shows a DDD pacemaker having two leads 30 and 32 for the unipolar electrodes 24 and 26.

The sensing of atrial and ventricular events in the embodiment of FIG. 3 functions in the same manner as described in connection with the embodiment of FIG. 1.

Another embodiment of a heart stimulator constructed in accordance with the principles of the present invention is shown in FIG. 4, similar to the embodiment of FIG. 1, but which includes an additional atrial pole 35. The atrial pole 35 is connected via a resistor R to a lead 42 running between the heart stimulator 14 and a ventricular sensing and stimulating pole 36. The value of the resistor is in the range of 1-20 kohms, and the resistor size is selected so that no stimulation occurs in the atrium through the lead 42, since the pole 36 in the ventricle has a lower resistance. The atrial pole 34 may also be connected to its lead 40 through a resistor, so that a balanced impedance is attained between the two atrial poles 34 and 35.

In this embodiment, detection of ventricular signals takes place in the same manner as described in the embodiments of FIGS. 1 and 3. The ventricular signal is normally much stronger than the atrial signal, and the sensitivity of the ventricular measurement unit 18 is therefore set so that only the relatively strong ventricular signals are detected, but not the weak atrial signals.

Detection of atrial events is made from the signal between the poles 34 and 35 in the atrium and between the pole 34 in the atrium and the pole 36 in the ventricle. When atrial cardiac activity is present, a differential signal is obtained between the pole 34 and the poles 35 and 36, the combination of the poles 35 and 36 serving as an signal is a measurement of atrial activity. The atrial measurement unit 16, however, also detects ventricular events, because the lead 42 sensing ventricular activity is connected to the atrial measurement unit 16. Ventricular activity is detected both by the unipolar ventricular detector 18 and by the differential atrial detector 16, whereas atrial events are detected only by the atrial detector 16. For this reason, logic gates 20 and 22 are used to define genuine atrial events as being atrial events which are detected without substantially contemporaneous ventricular detections, as described above.

The selection of atrial and ventricular events can be performed in some other manner than using the logic gates 20 and 22, as in the above-described embodiments.

FIG. 5 shows the chronology of the different signals obtained in the embodiment of FIG. 4. A conventional surface electrocardiogram signal Y(t) is shown at the top of FIG. 5, followed by a signal V which is the signal picked-up by the ventricular pole 36. Below that is shown a differential signal A1 -A2, which is the differential signal between the two leads 40 and 42. The signal Adet designates the output signal from the atrial measurement unit 16, and the signal Vdet designates the output signal from the ventricular measurement unit 18. The last signal At designates the output signal from the AND gate 20. The signal At thus designates genuine atrial events, i.e., the P-wave in the electrocardiogram, and Vdet designates genuine ventricular events, i.e., the QRS complex in the electrocardiogram.

FIG. 6 schematically illustrates one implementation of the type of heart stimulator according to the invention, as shown in FIG. 3, wherein the electrode leads 30 and 32 are bent in the atrial area so that the electrode 24 comes into contact with atrial tissue after implantation.

FIG. 7 schematically illustrates a practical implementation of the embodiment of FIG. 4.

FIG. 8 shows signals picked up by the heart stimulator constructed in accordance with the principles of the present invention in experiments conducted with a pig. The measurements were made using the embodiment shown in FIG. 3, with one well-positioned electrode in the atrium and another electrode in the ventricle. The upper signal channel CH1 shows the signal measured between the atrial and ventricular poles, i.e., the atrial signal, and the second signal channel CH2 shows the signal measured between the ventricular pole and the stimulator housing, i.e., the ventricular signal. In FIG. 8, atrial events are designated Ae and ventricular events Ve. As can be seen in FIG. 8, the atrial signal CH1 includes both atrial and ventricular events, whereas the ventricular signal CH2 only shows ventricular events. "Genuine" atrial events can be extracted from the measured atrial signal CH1 using the above-described logic gates, applied to the atrial signal CH1.

The above-described embodiments of the invention have been set forth in the context of a heart stimulator in the form of pacemaker. The principles of the present invention, however, can also be used in heart stimulators such as defibrillators.

Although modifications and changes may be suggested by those skilled in the art, it is the intention of the inventors to embody within the patent warranted hereon all changes and modifications as reasonably and properly come within the scope of their contribution to the art.

Claims (7)

We claim as our invention:
1. A heart stimulator comprising:
a housing;
a pulse generator contained in said housing;
electrode means for detecting atrial and ventricular activity including a pole adapted to be arranged in the atrium of a heart and a pole adapted to be arranged in the ventricle of said heart;
means for measuring atrial activity connected for measuring a signal between said pole adapted to be arranged in the atrium and at least said pole adapted to be arranged in the ventricle; and
means for measuring ventricular activity connected for measuring a signal between said pole adapted to be arranged in the ventricle and said housing.
2. A heart stimulator as claimed in claim 1 wherein said electrode means comprises at least one bipolar electrode having one pole thereon comprising said pole adapted to be arranged in the atrium and another pole thereon comprising said pole adapted to be arranged in the ventricle.
3. A heart stimulator as claimed in claim 1 wherein said electrode means comprises two unipolar electrodes respectively adapted to be arranged in the atrium and ventricle and respectively carrying said pole adapted to be arranged in the atrium and said pole adapted to be arranged in the ventricle.
4. A heart stimulator as claimed in claim 1 further comprising logic means connected to said means for measuring atrial activity and said means for measuring ventricular activity for approving signals from said means for measuring atrial activity as genuine atrial events only if no signal is supplied from said means for measuring ventricular activity within a specified period of time around a time at which said means for measuring atrial activity generates an atrial signal.
5. A heart stimulator as claimed in claim 1 wherein said electrode means comprises a first lead running from said pulse generator into said atrium and carrying said pole arranged in the atrium and a second lead running from said pulse generator to the ventricle and carrying said pole arranged in the ventricle, said second lead having a further pole thereon arranged in the atrium and a resistor connected between said further pole and said second lead, said means for measuring atrial activity being connected between said first and second leads and wherein said means for measuring atrial activity comprises means connected for measuring a signal between said pole adapted to be arranged in the atrium and said pole adapted to be arranged in the ventricle and said further pole adapted to be arranged in the atrium carried on said second lead.
6. A heart stimulator as claimed in claim 1 wherein said pole adapted to be arranged in the atrium comprises a pole adapted to be arranged in the atrium as a floating pole.
7. A heart stimulator as claimed in claim 1 wherein said electrode means comprises means adapted for placing said pole adapted to be arranged in the atrium in contact with atrial tissue for electrically stimulating said atrial tissue.
US08467267 1992-11-04 1995-06-06 Heart Stimulator Expired - Lifetime US5571143A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9203284 1992-11-04
SE9203284 1992-11-04
US14774493 true 1993-11-04 1993-11-04
US08467267 US5571143A (en) 1992-11-04 1995-06-06 Heart Stimulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08467267 US5571143A (en) 1992-11-04 1995-06-06 Heart Stimulator

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14774493 Continuation 1993-11-04 1993-11-04

Publications (1)

Publication Number Publication Date
US5571143A true US5571143A (en) 1996-11-05

Family

ID=20387701

Family Applications (1)

Application Number Title Priority Date Filing Date
US08467267 Expired - Lifetime US5571143A (en) 1992-11-04 1995-06-06 Heart Stimulator

Country Status (4)

Country Link
US (1) US5571143A (en)
EP (1) EP0596319B1 (en)
JP (1) JPH06190066A (en)
DE (2) DE69313778T2 (en)

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720768A (en) * 1996-05-22 1998-02-24 Sulzer Intermedics Inc. Dual chamber pacing with interchamber delay
EP0882469A2 (en) 1997-06-06 1998-12-09 Pacesetter AB Implatable heart stimulator
US5999853A (en) * 1998-03-02 1999-12-07 Vitatron Medical, B.V. Dual chamber pacemaker with single pass lead and with bipolar and unipolar signal processing capability
US20020099413A1 (en) * 1996-08-19 2002-07-25 Mower Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6539260B1 (en) 2000-02-28 2003-03-25 Pacesetter, Inc. Atrial sensing and pacing using a unipolar atrial electrode
US7047073B2 (en) 2000-11-17 2006-05-16 St. Jude Medical Ab Cardiac stimulating device
US7062318B2 (en) 1996-01-08 2006-06-13 Impulse Dynamics (Israel) Ltd Electrical muscle controller
US7647102B2 (en) 1999-10-25 2010-01-12 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and method of operating thereof
US7678573B2 (en) 1999-02-04 2010-03-16 Pluristem Ltd. Method of preparing a conditioned medium from a confluent stromal cell culture
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US7843439B2 (en) 2003-02-10 2010-11-30 N-Trig Ltd. Touch detection for a digitizer
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US7937148B2 (en) 2005-10-14 2011-05-03 Nanostim, Inc. Rate responsive leadless cardiac pacemaker
US7953481B1 (en) 1999-10-25 2011-05-31 Impulse Dynamics N.V. Anti-arrhythmic device and a method of delivering anti-arrhythmic cardiac therapy
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8447399B2 (en) 1996-08-19 2013-05-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US8615310B2 (en) 2010-12-13 2013-12-24 Pacesetter, Inc. Delivery catheter systems and methods
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US9020611B2 (en) 2010-10-13 2015-04-28 Pacesetter, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US9242102B2 (en) 2010-12-20 2016-01-26 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9511236B2 (en) 2011-11-04 2016-12-06 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69429797T2 (en) * 1993-09-24 2002-08-29 St Jude Medical A device for stimulation of the heart
DE69636715D1 (en) * 1995-11-28 2007-01-04 St Jude Medical Apparatus and method for producing a synthesized electrocardiogram
DE69826213T2 (en) * 1997-11-24 2006-03-02 St. Jude Medical Ab System for the detection of cardiac events for a pacemaker
DE60013608D1 (en) * 1999-07-19 2004-10-14 St Jude Medical Pacemaker

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903897A (en) * 1972-03-11 1975-09-09 Kent Cambridge Medical Ltd Cardiac pacer
US3977411A (en) * 1975-06-12 1976-08-31 Research Corporation Cardiac pacer system and method
US4023565A (en) * 1974-06-21 1977-05-17 Siemens Aktiengesellschaft Circuit arrangement for the processing of physiological measuring signals
US4154247A (en) * 1977-04-01 1979-05-15 Medtronic, Inc. Formable cardiac pacer lead and method of assembly and attachment to a body organ
US4213465A (en) * 1977-06-20 1980-07-22 Siemens Aktiengesellschaft Electroencephalograph
US4235246A (en) * 1979-02-05 1980-11-25 Arco Medical Products Company Epicardial heart lead and assembly and method for optimal fixation of same for cardiac pacing
US4245643A (en) * 1979-08-15 1981-01-20 Children's Hospital Medical Center Method and apparatus for measuring the ohmic contact resistance of an electrode attached to body tissue
DE2952818A1 (en) * 1979-12-28 1981-07-02 Biotronik Mess & Therapieg Electrode for an implantable pacemaker
US4567901A (en) * 1983-12-15 1986-02-04 Cordis Corporation Prebent ventricular/atrial cardiac pacing lead
US4630611A (en) * 1981-02-02 1986-12-23 Medtronic, Inc. Orthogonally-sensing lead
US4760852A (en) * 1985-09-09 1988-08-02 Siemens Aktiengesellschaft Heart pacemaker electrode having two portions of different conductive properties for stimulating and sensing
US4799486A (en) * 1987-03-13 1989-01-24 Cardiac Pacemakers, Inc. Refractoriless atrial sensing in dual chamber pacemakers
US4858610A (en) * 1985-12-11 1989-08-22 Telectronics, N.V. Detection of cardiac evoked potentials
US5085224A (en) * 1990-05-25 1992-02-04 Hewlett-Packard Company Portable signalling unit for an ekg
US5172694A (en) * 1991-05-30 1992-12-22 Vitatron Medical B.V. Single pacing lead and method utilizing two different floating bipoles
US5190052A (en) * 1990-11-21 1993-03-02 Intermedics, Inc. Pacer lead with bipolar electrode
US5235977A (en) * 1992-03-01 1993-08-17 Siemens Aktiengesellschaft Electrode arrangement for an implantable defibrillator/cardioverter

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903897A (en) * 1972-03-11 1975-09-09 Kent Cambridge Medical Ltd Cardiac pacer
US4023565A (en) * 1974-06-21 1977-05-17 Siemens Aktiengesellschaft Circuit arrangement for the processing of physiological measuring signals
US3977411A (en) * 1975-06-12 1976-08-31 Research Corporation Cardiac pacer system and method
US4154247A (en) * 1977-04-01 1979-05-15 Medtronic, Inc. Formable cardiac pacer lead and method of assembly and attachment to a body organ
US4213465A (en) * 1977-06-20 1980-07-22 Siemens Aktiengesellschaft Electroencephalograph
US4235246A (en) * 1979-02-05 1980-11-25 Arco Medical Products Company Epicardial heart lead and assembly and method for optimal fixation of same for cardiac pacing
US4245643A (en) * 1979-08-15 1981-01-20 Children's Hospital Medical Center Method and apparatus for measuring the ohmic contact resistance of an electrode attached to body tissue
DE2952818A1 (en) * 1979-12-28 1981-07-02 Biotronik Mess & Therapieg Electrode for an implantable pacemaker
US4630611A (en) * 1981-02-02 1986-12-23 Medtronic, Inc. Orthogonally-sensing lead
US4567901A (en) * 1983-12-15 1986-02-04 Cordis Corporation Prebent ventricular/atrial cardiac pacing lead
US4760852A (en) * 1985-09-09 1988-08-02 Siemens Aktiengesellschaft Heart pacemaker electrode having two portions of different conductive properties for stimulating and sensing
US4858610A (en) * 1985-12-11 1989-08-22 Telectronics, N.V. Detection of cardiac evoked potentials
US4799486A (en) * 1987-03-13 1989-01-24 Cardiac Pacemakers, Inc. Refractoriless atrial sensing in dual chamber pacemakers
US5085224A (en) * 1990-05-25 1992-02-04 Hewlett-Packard Company Portable signalling unit for an ekg
US5190052A (en) * 1990-11-21 1993-03-02 Intermedics, Inc. Pacer lead with bipolar electrode
US5172694A (en) * 1991-05-30 1992-12-22 Vitatron Medical B.V. Single pacing lead and method utilizing two different floating bipoles
US5235977A (en) * 1992-03-01 1993-08-17 Siemens Aktiengesellschaft Electrode arrangement for an implantable defibrillator/cardioverter

Cited By (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US8311629B2 (en) 1996-01-08 2012-11-13 Impulse Dynamics, N.V. Electrical muscle controller
US8306616B2 (en) 1996-01-08 2012-11-06 Impulse Dynamics, N.V. Electrical muscle controller
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US8306617B2 (en) 1996-01-08 2012-11-06 Impulse Dynamics N.V. Electrical muscle controller
US8301247B2 (en) 1996-01-08 2012-10-30 Impulse Dynamics, N.V. Electrical muscle controller
US7062318B2 (en) 1996-01-08 2006-06-13 Impulse Dynamics (Israel) Ltd Electrical muscle controller
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US5720768A (en) * 1996-05-22 1998-02-24 Sulzer Intermedics Inc. Dual chamber pacing with interchamber delay
US8290585B2 (en) 1996-08-19 2012-10-16 Mr3 Medical, Llc Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US20020099413A1 (en) * 1996-08-19 2002-07-25 Mower Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US8447399B2 (en) 1996-08-19 2013-05-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
EP0882469A2 (en) 1997-06-06 1998-12-09 Pacesetter AB Implatable heart stimulator
US5871507A (en) * 1997-06-06 1999-02-16 Pacesetter Ab Implantable cardiac assist device having differential signal detection between unipolar atrial and ventricular leads using signal morphology analysis
US5999853A (en) * 1998-03-02 1999-12-07 Vitatron Medical, B.V. Dual chamber pacemaker with single pass lead and with bipolar and unipolar signal processing capability
US7678573B2 (en) 1999-02-04 2010-03-16 Pluristem Ltd. Method of preparing a conditioned medium from a confluent stromal cell culture
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US7953481B1 (en) 1999-10-25 2011-05-31 Impulse Dynamics N.V. Anti-arrhythmic device and a method of delivering anti-arrhythmic cardiac therapy
US7647102B2 (en) 1999-10-25 2010-01-12 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and method of operating thereof
US6539260B1 (en) 2000-02-28 2003-03-25 Pacesetter, Inc. Atrial sensing and pacing using a unipolar atrial electrode
US7047073B2 (en) 2000-11-17 2006-05-16 St. Jude Medical Ab Cardiac stimulating device
US7843439B2 (en) 2003-02-10 2010-11-30 N-Trig Ltd. Touch detection for a digitizer
US8228311B2 (en) 2003-02-10 2012-07-24 N-Trig Ltd. Touch detection for a digitizer
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8326416B2 (en) 2003-03-10 2012-12-04 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8010209B2 (en) 2005-10-14 2011-08-30 Nanostim, Inc. Delivery system for implantable biostimulator
US8352025B2 (en) 2005-10-14 2013-01-08 Nanostim, Inc. Leadless cardiac pacemaker triggered by conductive communication
US8788053B2 (en) 2005-10-14 2014-07-22 Pacesetter, Inc. Programmer for biostimulator system
US8788035B2 (en) 2005-10-14 2014-07-22 Pacesetter, Inc. Leadless cardiac pacemaker triggered by conductive communication
US7937148B2 (en) 2005-10-14 2011-05-03 Nanostim, Inc. Rate responsive leadless cardiac pacemaker
US8798745B2 (en) 2005-10-14 2014-08-05 Pacesetter, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8295939B2 (en) 2005-10-14 2012-10-23 Nanostim, Inc. Programmer for biostimulator system
US8855789B2 (en) 2005-10-14 2014-10-07 Pacesetter, Inc. Implantable biostimulator delivery system
US9687666B2 (en) 2005-10-14 2017-06-27 Pacesetter, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US7945333B2 (en) 2005-10-14 2011-05-17 Nanostim, Inc. Programmer for biostimulator system
US9358400B2 (en) 2005-10-14 2016-06-07 Pacesetter, Inc. Leadless cardiac pacemaker
US9072913B2 (en) 2005-10-14 2015-07-07 Pacesetter, Inc. Rate responsive leadless cardiac pacemaker
US9872999B2 (en) 2005-10-14 2018-01-23 Pacesetter, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8457742B2 (en) 2005-10-14 2013-06-04 Nanostim, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US9192774B2 (en) 2005-10-14 2015-11-24 Pacesetter, Inc. Cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US9216298B2 (en) 2005-10-14 2015-12-22 Pacesetter, Inc. Leadless cardiac pacemaker system with conductive communication
US9227077B2 (en) 2005-10-14 2016-01-05 Pacesetter, Inc. Leadless cardiac pacemaker triggered by conductive communication
US9409033B2 (en) 2005-10-14 2016-08-09 Pacesetter, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US9272155B2 (en) 2009-02-02 2016-03-01 Pacesetter, Inc. Leadless cardiac pacemaker with secondary fixation capability
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
US9687655B2 (en) 2010-10-12 2017-06-27 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
US9020611B2 (en) 2010-10-13 2015-04-28 Pacesetter, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
US8615310B2 (en) 2010-12-13 2013-12-24 Pacesetter, Inc. Delivery catheter systems and methods
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
US9242102B2 (en) 2010-12-20 2016-01-26 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
US9511236B2 (en) 2011-11-04 2016-12-06 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell

Also Published As

Publication number Publication date Type
JPH06190066A (en) 1994-07-12 application
DE69313778D1 (en) 1997-10-16 grant
EP0596319A1 (en) 1994-05-11 application
DE69313778T2 (en) 1998-02-19 grant
EP0596319B1 (en) 1997-09-10 grant

Similar Documents

Publication Publication Date Title
US5855594A (en) Self-calibration system for capture verification in pacing devices
US5514161A (en) Methods and apparatus for controlling atrial stimulation in a double atrial triple chamber cardiac pacemaker
US6363281B1 (en) Cardiac rhythm management system and method
US6611712B2 (en) Apparatus and method for testing and adjusting a bipolar stimulation configuration
US7047083B2 (en) Method and apparatus for identifying lead-related conditions using lead impedance measurements
US6873875B1 (en) Implantable pulse generator and method having adjustable signal blanking
US4763646A (en) Heart pacemaker
US6067472A (en) Pacemaker system and method with improved evoked response and repolarization signal detection
US4759366A (en) Rate responsive pacing using the ventricular gradient
US5683426A (en) Apparatus and method for detecting the progression of AV nodal block and atrial capture
US5776168A (en) EGM recording system for implantable medical device
US6405087B1 (en) Cardiac stimulation system providing implantable device performance evaluation and method
US5782884A (en) Rate responsive cardiac pacemaker with peak impedance detection for rate control
US6882887B1 (en) Implantable lead and electrode portion
US5261418A (en) Cardiac lead with tensiometric element for providing signals corresponding to heart contractions
US6556859B1 (en) System and method for classifying sensed atrial events in a cardiac pacing system
US4532931A (en) Pacemaker with adaptive sensing means for use with unipolar or bipolar leads
US6622040B2 (en) Automatic selection of stimulation chamber for ventricular resynchronization therapy
US4674509A (en) System and method for detecting evoked cardiac contractions
US5443485A (en) Apparatus and method for capture detection in a cardiac stimulator
US5391192A (en) Automatic ventricular pacing pulse threshold determination utilizing an external programmer and a surface electrocardiogram
US5713935A (en) Method and apparatus for monitored biphasic cardiac impedance sensing
US5312446A (en) Compressed storage of data in cardiac pacemakers
US5233985A (en) Cardiac pacemaker with operational amplifier output circuit
US5702425A (en) Apparatus and method of noise classification in an implantable cardiac device

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12